Asudemotide

N/A

Report date: 2024/08/27 11:13:22

Base Information

Drug NameAsudemotide
Drug Alias NameS-588410S-288310/S-488410S-488310/S-288310S-288310/S-488310
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungEsophageal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncotherapy Science, Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncotherapy Science, IncShionogi & Co Ltd
Inactive CompaniesUniversity Of Tokyo
Active IndicationsUrinary Bladder NeoplasmsEsophageal Neoplasms
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A